Nicola Klein to Prospective Studies
This is a "connection" page, showing publications Nicola Klein has written about Prospective Studies.
Connection Strength
0.317
-
Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis. 2010 Jan 15; 201(2):214-22.
Score: 0.067
-
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):273-281.
Score: 0.042
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 Feb 01; 192(2):205-216.
Score: 0.041
-
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):141-150.
Score: 0.036
-
Evaluation of two frailty indices, with practical application in a vaccine clinical trial. Hum Vaccin Immunother. 2019; 15(12):2960-2968.
Score: 0.032
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.022
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.021
-
Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012 Feb 08; 307(6):598-604.
Score: 0.019
-
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011 Oct 26; 29(46):8279-84.
Score: 0.019
-
Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010 Jan; 29(1):1-5.
Score: 0.017